Diagnostic Accuracy Study for OWL-EVO1 As a Lung Cancer EVOC® Probe (Evolution Phase 2)

This study is testing a new breath test device (OWL-EVO1) that analyzes exhaled breath compounds to see if it can accurately detect lung cancer. **You may be eligible if...** - You are between 45 and 85 years old - You have had a CT scan of the chest in the last 6 months - Your BMI is between 16 and 40 - You are able to provide written informed consent **You may NOT be eligible if...** - You cannot breathe adequately on your own during the breath test (e.g., severe respiratory disease) - You have been in another clinical drug trial in the past 28 days - You have an inconclusive or indeterminate lung nodule on CT scan that is still under monitoring - You have had prior lung surgery beyond simple biopsy procedures - You have another cancer being investigated that hasn't been diagnosed yet Talk to your doctor to see if this trial is right for you.